- Dual inhibition - new trend in the treatment of dyslipidemias2003 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Dual inhibition of topoisomerases enhances apoptosis in melanoma cells2010 | Faculty of Medicine in Hradec Králové
- Dual inhibition - a new perspective2005 | First Faculty of Medicine
- Dual inhibition - a new perspective of the treatment of hypercholesterolaemia2003 | First Faculty of Medicine
- Twou sources of cholesterol and dual inhibition - a new perspective in hyperlipidemia treatment2004 | First Faculty of Medicine
- Renesance duální inhibice endopeptidáz a systému RAS v léčbě kardiovaskulárních onemocnění2016 | First Faculty of Medicine
- Dual inhibition: the results of IMPROVE-IT study - what is important for patients with diabetes2015 | First Faculty of Medicine
- New concept in the treatment of cardiovascular diseases - dual inhibition of neutral endopeptidase and RAA system2017 | First Faculty of Medicine
- Monitoring the dynamics of clinical and laboratory markers of chronic heart failure during 12 months of sacubitril/valsartan treatment2021 | First Faculty of Medicine
- Sacubitril/valsartan - new dual inhibitor of neprilysin and angiotensin II receptors2016 | First Faculty of Medicine
- Ve spojení a jednotě je síla2020 | First Faculty of Medicine
- ASCO 2020 virtual conference and treatment of lung cancer2020 | Publication without faculty affiliation
- Zoletorv - Pharmacological profile2017 | Faculty of Medicine in Pilsen
- Ezetimib, jeho účinky a uplatnění v léčbě dyslipidemií2017 | Faculty of Medicine in Pilsen
- Bimekizumab v léčbě psoriázy2022 | First Faculty of Medicine
- Studie PARADIGM-HF - Změna paradigmatu v léčbě chronického srdečního selhání?2015 | First Faculty of Medicine